Genomma Lab Internacional, S.A.B. de C.V.
$1.08+0.00%(+$0.00)
TickerSpark Score
85/100
96
Valuation
90
Profitability
80
Growth
80
Health
80
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GNMLF research report →
52-Week Range65% of range
Low $0.91
Current $1.08
High $1.17
Companywww.genommalab.com
Genomma Lab Internacional, S. A. B.
- CEO
- Juan Marco Sparvieri
- IPO
- 2012
- Employees
- 1,605
- HQ
- Mexico City, DF, MX
Price Chart
-0.92% · this period
Valuation
- Market Cap
- $1.06B
- P/E
- 9.28
- P/S
- 0.90
- P/B
- 1.32
- EV/EBITDA
- 4.81
- Div Yield
- 5.03%
Profitability
- Gross Margin
- 62.71%
- Op Margin
- 21.20%
- Net Margin
- 9.65%
- ROE
- 14.77%
- ROIC
- 14.44%
Growth & Income
- Revenue
- $17.52B · 1863.53%
- Net Income
- $1.61B · 7.54%
- EPS
- $1.65 · 7.84%
- Op Income
- $3.73B
- FCF YoY
- 769.18%
Performance & Tape
- 52W High
- $1.17
- 52W Low
- $0.91
- 50D MA
- $1.03
- 200D MA
- $1.04
- Beta
- 0.17
- Avg Volume
- 112
Get TickerSpark's AI analysis on GNMLF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our GNMLF Coverage
We haven't published any research on GNMLF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GNMLF Report →